share_log

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A：并购重组委托声明
美股sec公告 ·  05/03 17:27
Moomoo AI 已提取核心信息
60 Degrees Pharmaceuticals, Inc. (60P) has announced the scheduling of its 2024 Annual Meeting of Stockholders to be conducted virtually on July 16, 2024. The meeting will be accessible via live audio webcast, with no option for in-person attendance. Stockholders are invited to attend, register, obtain proxy materials, submit questions, and vote at the meeting. The company plans to make proxy materials available on or about June 6, 2024, primarily over the internet, to expedite delivery, reduce costs, and conserve resources. The meeting agenda includes the election of five directors, approval of an amendment to increase authorized shares under the 2022 Equity Incentive Plan, approval of a reverse stock split, modifications to the strike price of options for the CEO and CFO, issuance of options to a consultant, and the ratification of RBSM LLP as the independent auditor for the fiscal year ending December 31, 2024. The board recommends voting 'FOR' all proposals. The company emphasizes the importance of stockholder votes, regardless of attendance at the Annual Meeting.
60 Degrees Pharmaceuticals, Inc. (60P) has announced the scheduling of its 2024 Annual Meeting of Stockholders to be conducted virtually on July 16, 2024. The meeting will be accessible via live audio webcast, with no option for in-person attendance. Stockholders are invited to attend, register, obtain proxy materials, submit questions, and vote at the meeting. The company plans to make proxy materials available on or about June 6, 2024, primarily over the internet, to expedite delivery, reduce costs, and conserve resources. The meeting agenda includes the election of five directors, approval of an amendment to increase authorized shares under the 2022 Equity Incentive Plan, approval of a reverse stock split, modifications to the strike price of options for the CEO and CFO, issuance of options to a consultant, and the ratification of RBSM LLP as the independent auditor for the fiscal year ending December 31, 2024. The board recommends voting 'FOR' all proposals. The company emphasizes the importance of stockholder votes, regardless of attendance at the Annual Meeting.
60 Degrees Pharmicals, Inc.（60P）宣布其2024年年度股东大会计划于2024年7月16日虚拟举行。会议将通过网络直播进行观看，没有亲自出席的选项。邀请股东参加、注册、获取代理材料、提交问题并在会议上投票。该公司计划在2024年6月6日左右提供代理材料，主要通过互联网提供，以加快交付、降低成本和节省资源。会议议程包括选举五名董事，批准增加2022年股权激励计划下授权股份的修正案，批准反向股票拆分，修改首席执行官和首席财务官期权的行使价，向顾问发行期权，以及批准RBSM LLP作为截至2024年12月31日的财政年度的独立审计师。董事会建议对所有提案投赞成票。无论是否出席年会，该公司都强调股东投票的重要性。
60 Degrees Pharmicals, Inc.（60P）宣布其2024年年度股东大会计划于2024年7月16日虚拟举行。会议将通过网络直播进行观看，没有亲自出席的选项。邀请股东参加、注册、获取代理材料、提交问题并在会议上投票。该公司计划在2024年6月6日左右提供代理材料，主要通过互联网提供，以加快交付、降低成本和节省资源。会议议程包括选举五名董事，批准增加2022年股权激励计划下授权股份的修正案，批准反向股票拆分，修改首席执行官和首席财务官期权的行使价，向顾问发行期权，以及批准RBSM LLP作为截至2024年12月31日的财政年度的独立审计师。董事会建议对所有提案投赞成票。无论是否出席年会，该公司都强调股东投票的重要性。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息